[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353870-105":59,"doc-detail-353870-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","elevated-dock4-expression-correlates-with-favorable-prognosis-and-immune-infiltration-in-clear-cell-renal-cell-carcinoma","Elevated DOCK4 expression correlates with favorable prognosis and immune infiltration in clear cell renal cell carcinoma","","Background: Clear-cell renal cell carcinoma (ccRCC) is the most prevalent kidney cancer with limited treatment options, motivating biomarkers linked to outcomes and the tumor immune microenvironment. Methods: DOCK4 expression and prognosis were analyzed using tissue microarray (75 pairs) and a dataset of 532 cases, with Cox regression, nomogram construction, calibration, and Kaplan-Meier survival validation. Immune infiltration was assessed to connect DOCK4 with TIME. Results: DOCK4 was overexpressed in ccRCC; high expression related to improved survival and more favorable staging (AUC=0.819) and suggests enhanced immunotherapy susceptibility.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/elevated-dock4-expression-correlates-with-favorable-prognosis-and-immune-infiltration-in-clear-cell-renal-cell-carcinoma/353870/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/elevated-dock4-expression-correlates-with-favorable-prognosis-and-immune-infiltration-in-clear-cell-renal-cell-carcinoma/353870.png","ImageObject",300,407,{"name":92,"@type":93},"Mia  ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What is the study’s main focus regarding DOCK4 in ccRCC?","Question",{"text":113,"@type":114},"The study investigates DOCK4 expression in clear-cell renal cell carcinoma and its clinical significance, including whether it can act as a prognostic biomarker and relate to the tumor immune microenvironment.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was DOCK4 expression evaluated in this research?",{"text":118,"@type":114},"DOCK4 expression was analyzed using tissue microarray data (75 pairs) and an additional dataset of 532 cases, followed by univariate and multivariate Cox regression analyses.",{"name":120,"@type":111,"acceptedAnswer":121},"What relationship did the study find between high DOCK4 expression and patient outcomes?",{"text":122,"@type":114},"High DOCK4 expression was associated with more favorable pathologic staging and improved survival outcomes, with strong discrimination between tumor and normal samples (AUC=0.819).",{"name":124,"@type":111,"acceptedAnswer":125},"How might DOCK4 influence immunotherapy response?",{"text":126,"@type":114},"The results suggest that elevated DOCK4 may modulate the tumor immune microenvironment, potentially increasing susceptibility to immunotherapy and strengthening immune surveillance mechanisms.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},353870,1790193968,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":144,"language":145,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":67,"update_tm":149,"read_time":150,"preview_page_count":19,"preview_urls":151},687207024478,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","AnnAls of Medicine  \n2026, Vol. 58, no. 1, 2642533  \n[https://doi.org/10.1080/07853890.2026.2642533](https://doi.org/10.1080/07853890.2026.2642533)  \nRESEARCH ARTICLE     \nElevated DOCK4 expression correlates with favorable prognosis and immune infiltration in clear cell renal cell carcinoma  \nDa-Long Hea* , Fang-Fang Zhub*, Jia Wangc, Su-Wei Zhud and Shao-Shuai Houe  \nacollege of Basic Medicine, Jining Medical University, Jining, shandong, china; bdepartment of General Practice, shandong Provincial Hospital Affiliated to shandong first Medical University, Jinan, shandong, china; cThe school of clinical Medicine, Jining Medical University (Affiliated Hospital), Jining, shandong, china; ddepartment of critical-care Medicine, shandong Provincial Hospital Affiliated to shandong first Medical University, Jinan, shandong, china; edepartment of Pharmacy, Tengzhou central People’s Hospital, Affiliated Hospital of Jining Medical University, Tengzhou, shandong, china  \nABSTRACT  \nBackground: Clear-cell renal cell carcinoma (ccRCC), the most prevalent kidney cancer, has limited treatment options. This study investigated the expression and clinical significance of DOCK4 in ccRCC, hypothesizing that DOCK4 could serve as a prognostic biomarker and correlate with the tumor immune microenvironment (TIME) and immunotherapy response.  \nMethods: We comprehensively analyzed data on DOCK4 expression levels and prognostic outcomes in ccRCC patients derived from tissue microarray (75 pairs) and the dataset (532 cases). Based on univariate and multivariate Cox regression analyses, we constructed a prognostic nomogram and validated its predictive accuracy and risk stratification ability using calibration curves and Kaplan-Meier survival analysis. Immune cell infiltration analysis was conducted to investigate DOCK4’s role in the TIME.  \nResults: Analysis of DOCK4 expression in ccRCC tissues revealed its notable overexpression. High DOCK4 expression was associated with more favorable pathologic staging and improved survival outcomes. DOCK4 shows high discriminatory power between tumor and normal samples, with an area under the receiver operating characteristic (ROC) curve (AUC) of 0.819. This association was confirmed using tissue microarray analysis. Further investigation indicated that high DOCK4 expression may play a crucial role in modulating the TIME, potentially enhancing susceptibility to immunotherapy and strengthening immune surveillance mechanisms.  \nConclusions: DOCK4 is a promising prognostic biomarker in ccRCC, with high expression indicating favorable pathologic staging and improved survival. Its role in modulating the TIME suggests that DOCK4 could also serve as a therapeutic target, potentially guiding future immunotherapy strategies for this aggressive malignancy.  \nGRAPHICAL ABSTRACT  \nThis study integrates microarray and multiple database results to demonstrate that DOCK4 serves as a prognostic biomarker for clear cell renal cell carcinoma (ccRCC) and suggests its potential as a basis for guiding immunotherapy sensitivity assessment.  \nARTICLE HISTORY  \nReceived 28 October 2025 Accepted 27 February 2026  \nKEYWORDS  \nClear cell renal cell carcinoma; DOCK4; biomarker; immune infiltration; prognosis  \nCONTACT su-Wei Zhu  [suweizhu05051128@163.com](suweizhu05051128@163.com)  department of critical-care Medicine, shandong Provincial Hospital Affiliated to shandong first Medical University, Jinan, shandong, 250021, china; shao-shuai Hou  [hss9698@163.com](hss9698@163.com)  department of Pharmacy, Tengzhou central People’s Hospital, Affiliated Hospital of Jining Medical University, Tengzhou, shandong 277500, china.  \n*contributed equally  \n supplemental data for this article can be accessed online at [https://doi.org/10.1080/07853890.2026.2642533](https://doi.org/10.1080/07853890.2026.2642533) .  \n© 2026 The Author(s) . Published by informa UK limited, trading as Taylor & francis Group  \nThis is an open Access article distributed under the ","cbCaii8UmKW9wRQV","https://ap.wps.com/l/cbCaii8UmKW9wRQV","pdf",2960451,15,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Clinical challenge of ccRCC\n## DOCK4 biological context","[{\"question\":\"What is the study’s main focus regarding DOCK4 in ccRCC?\",\"answer\":\"The study investigates DOCK4 expression in clear-cell renal cell carcinoma and its clinical significance, including whether it can act as a prognostic biomarker and relate to the tumor immune microenvironment.\"},{\"question\":\"How was DOCK4 expression evaluated in this research?\",\"answer\":\"DOCK4 expression was analyzed using tissue microarray data (75 pairs) and an additional dataset of 532 cases, followed by univariate and multivariate Cox regression analyses.\"},{\"question\":\"What relationship did the study find between high DOCK4 expression and patient outcomes?\",\"answer\":\"High DOCK4 expression was associated with more favorable pathologic staging and improved survival outcomes, with strong discrimination between tumor and normal samples (AUC=0.819).\"},{\"question\":\"How might DOCK4 influence immunotherapy response?\",\"answer\":\"The results suggest that elevated DOCK4 may modulate the tumor immune microenvironment, potentially increasing susceptibility to immunotherapy and strengthening immune surveillance mechanisms.\"}]","Elevated DOCK4 expression correlates with favorable prognosis and immune infiltration in clear cell renal cell carcinoma | PDF",1790107666,38,[152,156,160,164],{"page_no":8,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e850fd4d48941be5f1f311122c5f8278.webp",983,1310,{"page_no":14,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b4a0e31eec545de47ea346ecd40f102b.webp",982,1309,{"page_no":81,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5ca786a0fdb3dc2b847ccefda2c5f255.webp",981,1308,{"page_no":19,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9f93d958cea3c8f9e41798c2a524dee0.webp",980,1306]